Meet the CCA Clinical Research Team

  • Dr. Scott Purga

    Dr. Scott Purga

    Dr. Scott Purga grew up in Schenectady. He graduated Summa Cum Laude from Boston University, College of Arts and Science with dual major in Medical Science and Psychology. While at Boston University, he was enrolled in the seven-year accelerated medical program, was a recipient of the Distinguished Sophomore Award (given to the Top 40 students of the class year), and honored Phi Beta Kappa. He received his medical degree from Boston University School of Medicine, where he was a recipient of the Anthony L.F. Gorman Prize in Physiology and honored Alpha Omega Alpha. While at Boston University, Dr. Purga was an Introduction to Clinical Medical Instructor. Dr. Purga’s post graduate training was at New York Presbyterian Hospital / Weill Cornell Medical Center with a residency in Internal Medicine. He subsequently completed a fellowship in Cardiovascular Disease at Albany Medical Center.

    Read more on Dr. Scott Purga

  • Dr. Eugene Pashkovetsky

    Dr. Eugene Pashkovetsky

    Dr. Eugene Pashkovetsky graduated Cum Laude from State University of New York Stony Brook with a major in Biology and minor in Chemistry. While at Stoney Brook, he was also on the Dean’s List, a member of Phi Beta Kappa, the Golden Key Honor Society, and National Society of Collegiate Scholars. He received his medical degree from St. George’s University School of Medicine (Grenada, West Indies), where he also taught all materials in Microbiology to medical students. Dr. Pashkovetsky’s post graduate training was at Northwell Health – Lenox Hill Hospital with a residency in Internal Medicine.

    Read Dr. Pashkovetsky’s full bio here

  • Dr. Parag Shah

    Dr. Parag Shah

    Dr. Parag Shah attended Guy’s Hospital in London, UK where he received his medical degree in 1987. In 1995, he completed a Fellowship in Cardiology at Albany Medical Center in Albany, NY.

    Dr. Shah is Board Certified in Cardiology. He is a Fellow of the American College of Cardiology. He is on staff at St. Peter’s Hospital and Albany Medical Center in Albany, NY.

    Dr. Shah’s cardiology specialities include: general cardiovascular disease with a special interest in permanent pacemaker implantation and transesophageal echocardiograms.

    Read more on Dr. Shah

Patricia Ryan RN, MSN Ed., PCCN i

Patricia Ryan RN, MSN Ed., PCCN is the CCA Clinical Research Manager. She brings five years of experience in acute and outpatient cardiology care to the department of research as a research coordinator/nurse. She received her Progressive Care Certification through The American Association of Critical Care Nursing in 2019. She obtained her Bachelor’s Degree in Nursing from Le Moyne College in 2017 and a Masters in Nursing Education through Western Governors University in 2021.

Current Clinical Research Studies

Capital Cardiology Associates is participating in the following clinical research studies

  • AMULET

    A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENCE OF MAJOR CARDIOVASCULAR EVENTS IN PATIENTS WITH, OR AT HIGH RISK

    FOR, CARDIOVASCULAR DISEASE WHO ARE STATIN INTOLERANT

    Read more on this study

    Not currently accepting participants.

  • This study is a multinational, multicentre, non-interventional, cohort study of assessment and treatment guideline recommendations in HF patient care in a real-world setting

    Read more on this study

    Now accepting patients!

  • A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENCE OF MAJOR CARDIOVASCULAR EVENTS IN PATIENTS WITH, OR AT HIGH RISK

    FOR, CARDIOVASCULAR DISEASE WHO ARE STATIN INTOLERANT

    Read more on this study

    Not currently accepting participants.

  • A double-blind randomized placebo-controlled trial assessing the effects of inclisiran on clinical outcomes among people with atherosclerotic cardiovascular disease

    Read more on this study

    Now accepting patients!

  • The Portico transcatheter aortic valve provides a minimally invasive treatment for patients diagnosed with severe aortic stenosis, an abnormal narrowing of the aortic valve. It is used in patients who may be at a high or extreme risk for open heart surgery

    – Not a good candidate for surgical valve replacement

    – Patient will either receive portico valve or commercially available valve

    *In conjunction with Albany Medical Center

    Read more on this study

    Now accepting patients!

  • o establish the safety and effectiveness of the Edwards SAPIEN 3 transcatheter heart valve in patients with severe, calcific aortic stenosis who are at low operative risk for standard aortic valve replacement(AVR)

    -Transcatheter Aortic Valve Replacement (TAVR) -VS- Surgical Aortic Valve Replacement (SAVR)

    -10 year study

    *In conjunction with Albany Medical Center

    Read more on this study

    Now accepting patients!